-
Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia.
-
Neuropathy occurs with a high frequency in patients with end-stage liver disease, but rarely causes disability.
-
Fixed dose of IVIg may not be effective in all patients with GBS.
-
Two studies have identified a novel inclusion found in a subset of FTLD brains and categorize the clinical entity of the behavioral variant of FTLD, based on anatomical patterns.
-
-
Glatiramer acetate significantly delayed the onset of clinically definite multiple sclerosis (MS) in patients having a clinically isolated event and brain lesions consistent with MS.
-
Dementia in Parkinson's disease is associated with a non-tremor-predominant phenotype, and the MAPT H1/H1 genotype. A rapidly progressing subtype without dementia has been identified, associated with another non-motor feature, depression.
-
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions.
-
Oculopharyngeal muscular dystrophy is a rare, autosomal dominant neuromuscular disorder that has recently been genetically defined and may be treatable with myoblast transplantation.
-
Hemicraniectomy in Older Patients with Large Middle Cerebral Artery Infarcts Reduces Mortality
